Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Cell Death & Disease
|
March 17, 2017
Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutations
Joel Fulton, Bismoy Mazumder, Jonathan B Whitchurch, et al.
British Journal of Cancer
|
February 14, 2024
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Theodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, et al.
Nature Genetics
|
January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
Luca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Nucleic Acids Research
|
September 20, 2013
Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells
Chun-Fui Lai, Koen D Flach, Xanthippi Alexi, et al.
Nature Communications
|
November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Communications
|
August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Breast Cancer Research and Treatment
|
July 8, 2010
The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells
Paul T R Thiruchelvam, Chun-Fui Lai, Hui Hua, et al.
Breast Cancer Research and Treatment
|
August 24, 2010
Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth
Robert S Tolhurst, Ross S Thomas, Fiona J Kyle, et al.
Cancer Research
|
July 30, 2009
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity
Simak Ali, Dean A Heathcote, Sebastian H B Kroll, et al.
Breast Cancer Research and Treatment
|
August 22, 2014
Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer
Bharath Rudraraju, Marjolein Droog, Tarek M A Abdel-Fatah, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Cell Death & Disease
|
March 17, 2017
Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutations
Joel Fulton, Bismoy Mazumder, Jonathan B Whitchurch, et al.
British Journal of Cancer
|
February 14, 2024
Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer
Theodora A Constantin, Anabel Varela-Carver, Kyle K Greenland, et al.
Nature Genetics
|
January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
Luca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Nucleic Acids Research
|
September 20, 2013
Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells
Chun-Fui Lai, Koen D Flach, Xanthippi Alexi, et al.
Nature Communications
|
November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Communications
|
August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Breast Cancer Research and Treatment
|
July 8, 2010
The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells
Paul T R Thiruchelvam, Chun-Fui Lai, Hui Hua, et al.
Breast Cancer Research and Treatment
|
August 24, 2010
Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth
Robert S Tolhurst, Ross S Thomas, Fiona J Kyle, et al.
Cancer Research
|
July 30, 2009
The development of a selective cyclin-dependent kinase inhibitor that shows antitumor activity
Simak Ali, Dean A Heathcote, Sebastian H B Kroll, et al.
Breast Cancer Research and Treatment
|
August 22, 2014
Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer
Bharath Rudraraju, Marjolein Droog, Tarek M A Abdel-Fatah, et al.
Page
of 12